المؤلفون: Baptist Gallwitz

المصدر: Frontiers in Endocrinology, Vol 13 (2022)

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin based therapy, glucose-depent insulinotropic peptide (GIP), dual agonists, tirzepatide, type 2 diabetes, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2022.1004044/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/1c3251ae9ce54acbb0d45cc30812eefdTest

المؤلفون: Mark M. Smits, Daniël H. Van Raalte

المصدر: Frontiers in Endocrinology, Vol 12 (2021)

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonist (GLP-1RA), oral, subcutaneous, semaglutide, type 2 diabetes, safety, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2021.786732/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/1d6095bb78274de5a98922ae3f3ed6dfTest

المؤلفون: Mark M. Smits, Daniël H. Van Raalte

المصدر: Frontiers in Endocrinology, Vol 12 (2021)

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonist (GLP-1RA), oral, subcutaneous, semaglutide, type 2 diabetes, safety, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2021.645563/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/c006b197be31425dac88ecfb77dea26fTest

المؤلفون: Juris J. Meier

المصدر: Frontiers in Endocrinology, Vol 12 (2021)

مصطلحات موضوعية: body weight, glycated hemoglobin (HbA1c), efficacy, glucagon-like peptide-1 receptor agonist (GLP-1RA), oral, semaglutide, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2021.645617/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/19a43517fb234f7698ccc2c0f0582ad9Test

المؤلفون: Baptist Gallwitz, Francesco Giorgino

المصدر: Frontiers in Endocrinology, Vol 12 (2021)

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonist (GLP-1RA), oral, subcutaneous, semaglutide, type 2 diabetes, Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: https://www.frontiersin.org/articles/10.3389/fendo.2021.645507/fullTest; https://doaj.org/toc/1664-2392Test

الوصول الحر: https://doaj.org/article/230b0452d57b40f7be78318186080144Test

المؤلفون: Hayashi, K, Yasuoka, T, Bando, Hiroshi, Miki, K, Nakagawa, M, Zushi, T, Suzuki, C, Shibata, R, Takata, T, Sato, M

مصطلحات موضوعية: Multiple daily insulin injection (MDI), Xultophy, Type 2 Diabetes Mellitus (T2DM), Bio-psycho-social, Glucagon like peptide-1 receptor agonist (GLP-1RA)

العلاقة: http://repo.lib.tokushima-u.ac.jp/files/public/11/116097/20210705161246184000/srmcr_2_2_126.pdfTest; http://repo.lib.tokushima-u.ac.jp/116097Test

الإتاحة: http://repo.lib.tokushima-u.ac.jp/116097Test

المؤلفون: Daisuke Yabe, Hitoshi Kuwata, Masahiro Iwasaki, Yutaka Seino

المصدر: European Medical Journal Diabetes, Vol 3, Iss 1, Pp 57-65 (2015)

مصطلحات موضوعية: dipeptidyl peptidase 4 (DPP-4) inhibitor, East Asian, glucagon-like peptide-1 receptor agonist (GLP-1RA), incretin, Type 2 diabetes mellitus (T2D), Diseases of the endocrine glands. Clinical endocrinology, RC648-665

وصف الملف: electronic resource

العلاقة: http://emjreviews.com/wp-content/uploads/Why-Are-Incretin-Based-Therapies-More-Efficient-in-East-Asians..-Perspectives-From-the-Pathophysiology-of-Type-2-Diabetes-and-East-Asian-Dietary-Habits.pdfTest; https://doaj.org/toc/2054-6181Test

الوصول الحر: https://doaj.org/article/343fcef49d0547c2a1886d16bf8cd1f8Test

المؤلفون: Daniël H. van Raalte, Mark M. Smits

المصدر: Smits, M M & van Raalte, D H 2021, ' Safety of Semaglutide ', Frontiers in Endocrinology, vol. 12, 645563 . https://doi.org/10.3389/fendo.2021.645563Test
Frontiers in Endocrinology
Frontiers in Endocrinology, Vol 12 (2021)

مصطلحات موضوعية: Blood Glucose, Time Factors, Endocrinology, Diabetes and Metabolism, Glucagon-Like Peptides, Type 2 diabetes, Review, 030204 cardiovascular system & hematology, Cardiovascular System, oral, 0302 clinical medicine, Endocrinology, Cholelithiasis, Medicine, Insulin, Clinical Trials as Topic, semaglutide, Gallbladder, Nausea, Acute Kidney Injury, glucagon-like peptide-1 receptor agonist (GLP-1RA), Drug class, subcutaneous, Patient Safety, type 2 diabetes, safety, medicine.medical_specialty, 030209 endocrinology & metabolism, Hypoglycemia, Glucagon-Like Peptide-1 Receptor, Diseases of the endocrine glands. Clinical endocrinology, 03 medical and health sciences, Pancreatic cancer, Animals, Humans, Hypoglycemic Agents, Thyroid Neoplasms, Adverse effect, Intensive care medicine, Pancreas, Glycemic, Diabetic Retinopathy, business.industry, Semaglutide, Body Weight, Correction, medicine.disease, RC648-665, Gastrointestinal Tract, Pancreatic Neoplasms, Clinical Trials, Phase III as Topic, Diabetes Mellitus, Type 2, Pancreatitis, business, Peptides

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d8e26575f2bb830c8a0a79dacab1f70Test
https://research.vumc.nl/en/publications/6fb96d2e-e862-4f22-bfd6-4a75b034f939Test

المؤلفون: Gallwitz B., Giorgino F.

المساهمون: Gallwitz, B., Giorgino, F.

مصطلحات موضوعية: glucagon-like peptide-1 receptor agonist (GLP-1RA), oral, semaglutide, subcutaneou, type 2 diabete, Administration, Body Weight, Cardiovascular Disease, Comorbidity, Decision Making, Diabetes Mellitus, Type 2, Dose-Response Relationship, Drug, Drug Administration Schedule, Glucagon-Like Peptide-1 Receptor, Glucagon-Like Peptide, Hemoglobin, Human, Hypoglycemia, Hypoglycemic Agent, Injections, Liver, Metformin, Obesity, Renal Insufficiency, Chronic, Research Design, Risk, Stomach

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34267725; info:eu-repo/semantics/altIdentifier/wos/WOS:000674134300001; volume:12; firstpage:645507; journal:FRONTIERS IN ENDOCRINOLOGY; http://hdl.handle.net/11586/391791Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85110105284

الإتاحة: https://doi.org/10.3389/fendo.2021.645507Test
http://hdl.handle.net/11586/391791Test

المؤلفون: Patti A. M., Giglio R. V., Papanas N., Rizzo Manfredi, Rizvi A. A.

المساهمون: Patti A.M., Giglio R.V., Papanas N., Rizzo Manfredi, Rizvi A.A.

مصطلحات موضوعية: Dipeptidyl peptidase-4 inhibitors (DPP-4is), dyslipidemia, ezetimibe, fibrate, Lipid, glucagon like peptide-1 receptor agonist (GLP-1RA), proprotein convertase subtilisin/kexin type 9 (PCSK9), sodium/glucose cotransporter 2 inhibitors (SGLT-2is), Diabetes Mellitus, Type 2, Hydroxymethylglutaryl-CoA Reductase Inhibitor, statins, Cardiovascular Diseases

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/30644763; info:eu-repo/semantics/altIdentifier/wos/WOS:000457422900008; volume:12; issue:2; firstpage:129; lastpage:143; numberofpages:15; journal:EXPERT REVIEW OF CLINICAL PHARMACOLOGY; http://hdl.handle.net/10447/433792Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85060956188

الإتاحة: https://doi.org/10.1080/17512433.2019.1567328Test
http://hdl.handle.net/10447/433792Test